|
Join Jennifer A. Romanski, Managing Director at Porzio Life Sciences and Principal at Porzio, Bromberg & Newman as she presents an OPDP Year In Review. Thursday, January 26th beginning at 12:00 pm EST. Jennifer will highlight key aspects of warning and untitled letters issued by the FDA's Office of Prescription Drug Promotion ("OPDP") in 2022, consider trends based on the FDA's guidance and prior enforcement letters, and remind viewers of related regulatory requirements. To register, click HERE.
|
